Anti-HBV Recombinant Antibody (Exbivirumab) (CAT#: TAB-746)

Recombinant human monoclonal antibody expressed in CHO binding to HBV. Exbivirumab is a human monoclonal antibody developed for the treatment of hepatitis B infections.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-HBV Recombinant Antibody (TAB-746) in SDS-PAGE

Figure 1 Anti-HBV Recombinant Antibody (TAB-746) in SDS-PAGE

Lane 1: 1 μg, Non-Reducing Lane 2: 2 μg, Reducing


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - lambda
  • Species Reactivity
  • HBV
  • Applications
  • Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
  • Trade name
  • hepex-b
  • CAS
  • 569658-80-6
  • Generic Name
  • exbivirumab
  • MW
  • 144,446.75 g/mol
  • Related Disease
  • Hepatitis B reinfection in liver transplant patients

Product Property

  • Purity
  • Purity >95% by SDS-PAGE.
  • Storage
  • Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.

Target

  • Alternative Names
  • exbivirumab;hepex-b;569658-80-6;19.79.5;HbsAg;HBV;Major surface antigen

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Exbivirumab"

Afuco™ Anti-HBV ADCC Recombinant Antibody (Exbivirumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to HBV. Exbivirumab is a human monoclonal antibody developed for the treatment of hepatitis B infections.

See other products for "HBV"

Single-domain Antibody

CAT Product Name Application Type
NAB-1234-sdAb Recombinant Anti-HBV VHH Single Domain Antibody IHC, IP, FC, Neut, FUNC Llama VHH

Human Antibody

CAT Product Name Application Type
TAB-879 Anti-Human Hepatitis B virus Recombinant Antibody (Tuvirumab) Inhib, ELISA IgG1 - lambda

Humanized Antibody

Mouse Antibody

CAT Product Name Application Type
PABX-078-S (P) Recombinant Human Anti-Hepatitis B virus Antibody scFv Fragment (KR127) WB, ELISA, FuncS scFv

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-746 Afuco™ Anti-HBV ADCC Recombinant Antibody (Exbivirumab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
AFC-TAB-879 Afuco™ Anti-HBV ADCC Recombinant Antibody (Tuvirumab), ADCC Enhanced ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-746. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare